SCHEMBL14867907

SCHEMBL14867907

c1ccc(-c2cccc(-c3ccc4oc5ccc(-n6c7ccc(-n8c9ccccc9c9ccccc98)cc7c7cc(-n8c9ccccc9c9ccccc98)ccc76)cc5c4c3)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.42
PLA2G4A P47712 4/20 0.42
PLA2G10 O15496 1/20 0.42
KDM4E B2RXH2 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ATM Q13315 1/20 0.41
PRKDC P78527 3/20 0.40
TSPO P30536 3/20 0.38
EDNRB P24530 1/20 0.36
EDNRA P25101 1/20 0.36
PGR P06401 1/20 0.36
HDAC4 P56524 1/20 0.36
RAC2 P15153 1/20 0.34
RAC3 P60763 1/20 0.34
CDC42 P60953 1/20 0.34
RAC1 P63000 1/20 0.34
MAPT P10636 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19336643 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL17166632 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL17166709 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL20097833 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL16482593 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL16482331 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL17166642 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL16482270 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL18090562 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL17166623 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895966-B2 Material for organic electroluminescence element, and organic electroluminescence element using same IDEMITSU KOSAN CO., LTD. (JP) 2014-11-25 US disclosed
US-8895966-B2 Material for organic electroluminescence element, and organic electroluminescence element using same IDEMITSU KOSAN CO., LTD. (JP) 2014-11-25 US disclosed
US-20130092905-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-04-18 US disclosed
US-20130092905-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130092905-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME LEF1, ORMDL3, CD99 PLA2G2A 4507/4885PLA2G4A 4633/4885PLA2G10 4609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.